Edition:
United States

Baxter International Inc (BAX)

BAX on New York Consolidated

44.01USD
2 Dec 2016
Change (% chg)

$0.38 (+0.87%)
Prev Close
$43.63
Open
$43.78
Day's High
$44.20
Day's Low
$43.69
Volume
5,933,939
Avg. Vol
4,191,689
52-wk High
$50.16
52-wk Low
$34.06

Latest Key Developments (Source: Significant Developments)

Baxter International Inc gives FY, Q1 2016 guidance
Tuesday, 2 Feb 2016 07:00am EST 

Baxter International Inc:Expects FY 2016 sales to increase 2 to 3 percent excluding the impact of foreign exchange, and after adjusting for the impact of both foreign exchange and increased U.S. competition for cyclophosphamide, the company expects full-year sales growth of 3 to 4 percent.Says that on a reported basis, including the impact of foreign exchange, Baxter expects sales to decline about 1 percent.Expects earnings from continuing operations, before special items, of $1.46 to $1.54 per diluted share for FY 2016.Expects Q1 2016 expects sales to grow 3 to 4 percent, on a constant currency basisSays.On reported basis, including impact of foreign exchange, the company expects sales to decline about 2 percent.Expects earnings from continuing operations, before special items, of $0.28 to $0.30 per diluted share for Q1 2016.  Full Article

Baxter International Inc - Baxter Initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter - ENPNWS
Monday, 25 Jan 2016 07:15am EST 

Baxter International Inc:Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level due to the potential for leaking containers and particulate matter. - ENPNWS.Baxter was made aware of these issues as the result of two complaints for leaking containers and one customer complaint each for three lots due to particulate matter. - ENPNWS.In each case, the issue was discovered prior to patient administration and there have been no adverse events associated with these incidents reported to Baxter to date. - ENPNWS.Leaking containers could result in contamination of the solution. If not detected, this could lead to a bloodstream infection, worsened patient condition or other serious adverse health consequences. - ENPNWS.Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack, damage to other organs such as the kidney or liver, or death. - ENPNWS.There is also the possibility of allergic reactions, local irritation and inflammation in tissues and organs. - ENPNWS.  Full Article

Baxter International Inc - Recalls continue to dog Baxter - CHITRI
Thursday, 7 Jan 2016 06:16am EST 

Baxter International Inc:Baxter International, the Deerfield-based maker of hospital and renal products, continued to be dogged with product-quality issues in 2015 as it issued at least five recalls on products from IV solutions to vascular patches - RTRS.Contaminated hospital supplies can be life-threatening, resulting in strokes, heart attacks and organ damage. - RTRS.A string of recalls could raise questions about a supplier's manufacturing and quality-control safeguards - RTRS.In the wake of the recalls, a new CEO, Jose Almeida, took the helm at Baxter this week, with a mission to rebuild the 84-year-old company. - RTRS.Baxter is dealing with the challenge of mature product lines and a slow-growing revenue base after the spinoff last summer of its pharmaceutical operations into the newly formed Baxalta Inc - RTRS.For Baxter, recalls are an ongoing issue. - RTRS.The Food and Drug Administration website shows numerous recalls each year for the past several years, with some that cost the company millions of dollars. - RTRS.  Full Article

Baxter International Inc declares quarterly dividend
Tuesday, 10 Nov 2015 08:55am EST 

Baxter International Inc:Declared a regular quarterly dividend of $0.115 per Baxter common share.Payable on January 4, 2016 to shareholders of record date as of December 4.  Full Article

Baxter International names new chairman and chief executive officer
Wednesday, 28 Oct 2015 04:45pm EDT 

Baxter International Inc:Has named José (Joe) Almeida the company's Chairman and Chief Executive Officer (CEO), effective Jan. 1, 2016.Almeida will join the company immediately as an executive officer to facilitate a smooth leadership transition.Almeida, 53, will succeed Robert L. Parkinson, Jr., who has served as the company's Chairman and CEO since 2004 and will retire from these roles Jan. 1, 2016, with a brief transition period thereafter.Upon retirement, Parkinson will assume the title of Chairman Emeritus.  Full Article

Baxter International Inc to cut 1,400 jobs worldwide to boost profits - Reuters
Tuesday, 27 Oct 2015 12:42pm EDT 

Baxter International Inc:Baxter International Inc said on Tuesday it plans to cut about 1,400 jobs worldwide, or about 5 percent of its non-manufacturing workforce, as part of a broad effort to reduce costs and boost profits - RTRS.About two-thirds of the job cuts are planned for outside the United States, with the lay-offs to be completed by the end of the year, Chief Executive Bob Parkinson said on the company's third-quarter earnings call - RTRS.The reduction is expected to save about $130 million a year, he said - RTRS.  Full Article

Baxter International Inc comments on Q4 2015 sales guidance
Tuesday, 27 Oct 2015 06:30am EDT 

Baxter International Inc:Sees Q4 2015 sales to decline 1 percent, excluding the impact of foreign exchange.  Full Article

Baxter International Inc announces U.S. FDA clearance for AMIA automated peritoneal dialysis system
Tuesday, 13 Oct 2015 08:01am EDT 

Baxter International Inc:Says FDA has granted 510(k) clearance for AMIA automated peritoneal dialysis system with SHARESOURCE web-based remote connectivity platform to provide peritoneal dialysis for treatment of end-stage renal disease.Says anticipates launching the Amia APD system with sharesource in the United States in 2015.  Full Article

Baxter International Inc Initiates Voluntary Nationwide Recall Of One Lot Of IV Solution Due To The Potential For Leaking Containers, Particulate Matter And Missing Port - FDA
Wednesday, 29 Jul 2015 08:00pm EDT 

Baxter International Inc:Says it is voluntarily recalling one lot of intravenous (IV) solution to the hospital/user level due to the potential for leaking containers, particulate matter and missing port protectors. Baxter was made aware of these issues through customer complaints - FDA.Says Leaking containers, particulate matter and missing port protectors could result in contamination of the solution.Says If not detected, this could lead to a bloodstream infection or other serious adverse health consequences.Says Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack or damage to other organs such as the kidney or liver.  Full Article

Baxter International Inc declares quarterly dividend
Wednesday, 29 Jul 2015 04:10pm EDT 

Baxter International Inc:Declares a regular quarterly dividend of $0.115 per Baxter common share.This cash dividend is payable on October 1, 2015 to shareholders of record as of September 4, 2015.  Full Article

BRIEF-Baxter presented exploratory research on the removal of inflammation-related molecules during extracorporeal blood purification therapy

* Baxter International Inc - presented exploratory research on the removal of inflammation-related molecules during extracorporeal blood purification therapy